The Week Ahead: Hom...
Health Care: Drugs
Alexza Pharmaceuticals Inc. (ALXA: NASDAQ)
$4.39 -0.04 | -0.90%
05/17/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with ALXA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorDrugs Facing FDA Approval i...
Latest ALXA Headlines from TheStreet
- Top Insider Trades: AEGR VVTV CCO ALXA 01.23.13 | 08:01 am
- 5 Stocks With Big Insider Buying 01.02.13 | 11:01 am
- 13 Biotech Stock Predictions for 2013 01.02.13 | 06:01 am
- Shorting Alexza Pharma On FDA's Adasuve Approval 12.19.12 | 07:12 am
- 6 Stocks On Winning Streaks Short Sellers Do Not Believe In 12.18.12 | 04:12 pm
- Stocks Socked Despite Upbeat China Numbers; Apple Falls 12.14.12 | 04:12 pm
- The Next Big Thing in Biotech: FDA Decisions
12.14.12 | 05:12 am - Alexza Pharma: Premium Selling Options Strategy 12.12.12 | 11:12 am
- Alexza Pharma: Run-Up Trade Into December's Approval Decisions 11.20.12 | 08:11 am
- 21 Most Volatile Biopharma Stocks Closing Out 2012 11.05.12 | 06:11 am
Press Releases for ALXA
- Peter W. Schineller Joins Alexza Pharmaceuticals As Senior Vice President And Chief Commercial Officer - PR Newswire 03.13.13 | 09:03 am
- Alexza To Report 2012 Year-End Financial Results On Tuesday, March 26, 2013 - PR Newswire 03.06.13 | 05:03 pm
- Alexza Pharmaceuticals' Corporate Presentation To Be Webcast At Three Upcoming Investor Conferences - PR Newswire 02.25.13 | 09:02 am
- Alexza Receives Marketing Authorization For ADASUVE® (Staccato® Loxapine) In The European Union - PR Newswire 02.21.13 | 09:02 am
- Alexza Pharmaceuticals Appoints J. Kevin Buchi To Its Board Of Directors - PR Newswire 01.03.13 | 09:01 am
- U.S. FDA Approves Alexza's ADASUVE® (loxapine) Inhalation Powder For The Acute Treatment Of Agitation Associated With Schizophrenia Or Bipolar I Disorder In Adults - PR Newswire 12.21.12 | 03:12 pm
- The CHMP Delivers A Positive Opinion Recommending Grant Of Marketing Authorization For ADASUVE® (Staccato® Loxapine) In The European Union - PR Newswire 12.14.12 | 08:12 am
- Alexza Pharmaceuticals Receives Updated Day 180 List Of Outstanding Issues For ADASUVE⢠(Staccato® Loxapine) MAA - PR Newswire 11.19.12 | 09:11 am
- Alexza Pharmaceuticals' Staccato® Technology Receives Frost & Sullivan Enabling Technology Award - PR Newswire 10.18.12 | 05:10 pm
- Alexza Announces Third Quarter 2012 Financial Results Teleconference And Webcast - PR Newswire 10.17.12 | 04:10 pm
Partner Headlines for ALXA
- After-Hours Earnings Report for May 14, 2013 : A, EXP, VIPS, PLAB, VOXX, ATHX, FENG, ALXA, TKMR, PRMW, QBAK, TXCC - NASDAQ 05.14.13 | 06:05 pm
- Alexza Pharmaceuticals Earnings Preview: Get Ahead of the Analysts - Wall St. Cheat Sheet 05.13.13 | 03:05 am
- Alexza Pharmaceuticals: Here’s What Investors Need to Know Before Earnings - Wall St. Cheat Sheet 05.09.13 | 02:05 am
- BioPharma Stock Movers For Wednesday, August 29 - Seeking Alpha 08.29.12 | 09:08 am
- 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year - Seeking Alpha 08.28.12 | 09:08 am
- Good News for Alexza Pharma - Analyst Blog - NASDAQ 08.23.12 | 02:08 pm
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 07.20.12 | 09:07 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 07.18.12 | 09:07 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 07.16.12 | 09:07 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 07.10.12 | 09:07 am
